Expression and regulation of interferon-related development regulator-1 in cystic fibrosis neutrophils

American Journal of Respiratory Cell and Molecular Biology

Volumn 48, Issue 1, 2013, Pages 71-77

  Hector, Andreas ^a   Kormann, Michael ^a   Kammermeier, Julia ^b   Burdi, Sofia ^b   Marcos, Veronica ^b   Rieber, Nikolaus ^a   Mays, Lauren ^a   Illig, Thomas ^c,d   Klopp, Norman ^c,d   Falkenstein, Fabian ^b   Kappler, Matthias ^b   Riethmueller, Joachim ^a   Graepler Mainka, Ute ^a   Stern, Martin ^a   Eickmeier, Olaf ^e   Serve, Friederike ^e   Zielen, Stefan ^e   Dor̈ing, Gerd ^a   Griese, Matthias ^b   Hartl, Dominik ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e GOETHE UNIVERSITY   (Germany)

Author keywords

Cystic fibrosis; IFRD1; Inflammation; Innate immunity; Neutrophils

Indexed keywords

CELL PROTEIN; CXCL2 CHEMOKINE; INTERFERON RELATED DEVELOPMENT REGULATOR 1; INTERLEUKIN 8; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DOWN REGULATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG FUNCTION; MAJOR CLINICAL STUDY; NEUTROPHIL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

CASE-CONTROL STUDIES; CHEMOKINE CXCL2; COHORT STUDIES; CYSTIC FIBROSIS; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNITY, INNATE; INTERLEUKIN-8; LUNG; NEUTROPHILS; POLYMORPHISM, SINGLE NUCLEOTIDE; REACTIVE OXYGEN SPECIES;

EID: 84871914687     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2012-0061OC     Document Type: Article

References (35)

1. Dodge JA, Morison S, Lewis PA, Coles EC, Geddes D, Russell G, Littlewood JM, Scott MT. Incidence, population, and survival of cystic fibrosis in the UK, 1968-95: UK Cystic Fibrosis Survey Management Committee. Arch Dis Child 1997;77:493-496.
2. Elizur A, Cannon CL, Ferkol TW. Airway inflammation in cystic fibrosis. Chest 2008;133:489-495. (Pubitemid 351272410)
3. Accurso FJ. Update in cystic fibrosis 2005. Am J Respir Crit Care Med 2006;173:944-947.
4. Ranganathan SC, Parsons F, Gangell C, Brennan S, Stick SM, Sly PD. Evolution of pulmonary inflammation and nutritional status in infants and young children with cystic fibrosis. Thorax 2011;66:408-413.
5. Regamey N, Tsartsali L, Hilliard TN, Fuchs O, Tan HL, Zhu J, Qiu YS, Alton EW, Jeffery PK, Bush A, et al. Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis. Thorax 2012;67:164-170.
6. Kerem E, Corey M, Kerem BS, Rommens J, Markiewicz D, Levison H, Tsui LC, Durie P. The relation between genotype and phenotype in cystic fibrosis: analysis of the most common mutation (delta F508). N Engl J Med 1990;323:1517-1522.
7. Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 1993;329:1308-1313.
8. Bremer LA, Blackman SM, Vanscoy LL, McDougal KE, Bowers A, Naughton KM, Cutler DJ, Cutting GR. Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis. Hum Mol Genet 2008;17:2228-2237. (Pubitemid 351916579)
9. Collaco JM, Cutting GR. Update on gene modifiers in cystic fibrosis. Curr Opin Pulm Med 2008;14:559-566.
10. Cutting GR. Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann N Y Acad Sci 2010;1214:57-69.
11. Cutting GR. Modifier genetics: cystic fibrosis. Annu Rev Genomics Hum Genet 2005;6:237-260. (Pubitemid 41397083)
12. Vanscoy LL, Blackman SM, Collaco JM, Bowers A, Lai T, Naughton K, Algire M, McWilliams R, Beck S, Hoover-Fong J, et al. Heritability of lung disease severity in cystic fibrosis. Am J Respir Crit Care Med 2007;175:1036-1043. (Pubitemid 46741755)
13. Wright FA, Strug LJ, Doshi VK, Commander CW, Blackman SM, Sun L, Berthiaume Y, Cutler D, Cojocaru A, Collaco JM, et al. Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. Nat Genet 2011;43:539-546.
14. Becker T, Jansen S, Tamm S, Wienker TF, Tummler B, Stanke F. Transmission ratio distortion and maternal effects confound the analysis of modulators of cystic fibrosis disease severity on 19q13. Eur J Hum Genet 2007;15:774-778. (Pubitemid 46965411)
15. Stanke F, Becker T, Hedtfeld S, Tamm S, Wienker TF, Tummler B. Hierarchical fine mapping of the cystic fibrosis modifier locus on 19q13 identifies an association with two elements near the genes CEACAM3 and CEACAM6. Hum Genet 2010;127:383-394.
16. Vietor I, Huber LA. Role of TIS7 family of transcriptional regulators in differentiation and regeneration. Differentiation 2007;75:891-897. (Pubitemid 350086169)
17. Gu Y, Harley IT, Henderson LB, Aronow BJ, Vietor I, Huber LA, Harley JB, Kilpatrick JR, Langefeld CD, Williams AH, et al. Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease. Nature 2009;458:1039-1042.
18. Ehrnhoefer DE. IFRD1 modulates disease severity in cystic fibrosis through the regulation of neutrophil effector function. Clin Genet 2009;76:148-149.
19. Theilgaard-Monch K, Jacobsen LC, Borup R, Rasmussen T, Bjerregaard MD, Nielsen FC, Cowland JB, Borregaard N. The transcriptional program of terminal granulocytic differentiation. Blood 2005;105: 1785-1796. (Pubitemid 40223703)
20. Adcock IM, Ito K, Barnes PJ. Histone deacetylation: an important mechanism in inflammatory lung diseases. COPD 2005;2:445-455. (Pubitemid 43879443)
21. Montuschi P, Kharitonov SA, Ciabattoni G, Corradi M, van Rensen L, Geddes DM, Hodson ME, Barnes PJ. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 2000;55:205-209. (Pubitemid 30245970)
22. Hayes E, Pohl K, McElvaney NG, Reeves EP. The cystic fibrosis neutrophil: a specialized yet potentially defective cell. Arch Immunol Ther Exp (Warsz) 2011;59:97-112.
23. Schluchter MD, Konstan MW, Drumm ML, Yankaskas JR, Knowles MR. Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data. Am J Respir Crit Care Med 2006;174:780-786. (Pubitemid 44511659)
24. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
25. Kormann MS, Ferstl R, Depner M, Klopp N, Spiller S, Illig T, Vogelberg C, von Mutius E, Kirschning CJ, Kabesch M. Rare TLR2 mutations reduce TLR2 receptor function and can increase atopy risk. Allergy 2009;64:636-642.
26. Hector A, Jonas F, Kappler M, Feilcke M, Hartl D, Griese M. Novel method to process cystic fibrosis sputum for determination of oxidative state. Respiration 2010;80:393-400.
27. Hartl D, Latzin P, Hordijk P, Marcos V, Rudolph C, Woischnik M, Krauss-Etschmann S, Koller B, Reinhardt D, Roscher AA, et al. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 2007;13:1423-1430. (Pubitemid 350224252)
28. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics 1997;53:1253-1261. (Pubitemid 28013569)
29. Kujubu DA, Lim RW, Varnum BC, Herschman HR. Induction of transiently expressed genes in PC-12 pheochromocytoma cells. Oncogene 1987;1:257-262. (Pubitemid 17149185)
30. Guardavaccaro D, Montagnoli A, Ciotti MT, Gatti A, Lotti L, Di Lazzaro C, Torrisi MR, Tirone F. Nerve growth factor regulates the subcellular localization of the nerve growth factor-inducible protein PC4 in PC12 cells. J Neurosci Res 1994;37:660-674. (Pubitemid 24119380)
31. Tirone F, Shooter EM. Early gene regulation by nerve growth factor in PC12 cells: induction of an interferon-related gene. Proc Natl Acad Sci USA 1989;86:2088-2092. (Pubitemid 19087074)
32. Hartl D, Griese M, Kappler M, Zissel G, Reinhardt D, Rebhan C, Schendel DJ, Krauss-Etschmann S. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J Allergy Clin Immunol 2006;117:204-211. (Pubitemid 43017162)
33. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, Berger M. Inflammatory cytokines in cystic-fibrosis lungs. Am J Respir Crit Care Med 1995;152:2111-2118.
34. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, et al. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 2005;353:1443-1453. (Pubitemid 41400918)
35. Blanchard E, Marie S, Riffault L, Bonora M, Tabary O, Clement A, Jacquot J. Reduced expression of Tis7/IFRD1 protein in murine and human cystic fibrosis airway epithelial cell models homozygous for the F508del-CFTR mutation. Biochem Biophys Res Commun 2011;411:471-476.